Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Altman currently holds 274,766 shares of BioCardia, Inc. (BCDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Altman has been a net buyer of BCDA stock. They have purchased $486.6K and sold $7.4K worth of shares.
Peter Altman's most recent insider trade was on Mar 25, 2026, when they purchased 300 shares at $1.22 per share.
Peter Altman serves as Executive at BioCardia, Inc. (BCDA). They have executed 119 insider transactions totaling $494.0K over their tenure at the company.
Peter Altman holds the position of Executive at BioCardia, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Peter Altman has shown a buying trading pattern, with $486.6K in total purchases and $7.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Altman was on May 18, 2023, when they purchased $185.9K worth of BCDA;BCDAW shares. This transaction involved 109,324 shares at $1.70 per share.
Peter Altman currently owns 274,766 shares of BioCardia, Inc. (BCDA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Altman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Altman has 119 Form 4 filings on record as an insider at BioCardia, Inc..
Set alerts for Peter Altman and 40,000+ other insiders.